A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP)
Clinical trial NCT06355531 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06355531
- Sponsor
- Ferrer Internacional S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-23
- Primary completion
- 2026-11-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.